Evidence map›Paper›PMID 40877832›Full record

ArticleBMC psychiatry2025

The associations between insomnia symptoms and clinical features, lipid metabolism parameters, as well as inflammatory cytokines in patients with chronic schizophrenia.

Lewei Liu, Zhenkuo Li, Jiawei Wang, Lili Zhao, Xi Zhang, Yinghan Tian, Xianhu Yao, Wenzheng Li, Lei Xia, Huanzhong Liu

Abstract read
In one paragraph

Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lewei Liu *Department of Psychiatry, The Fourth Affiliated Hospital of Anhui Medical University, 64 Chaohu North Road, Hefei, Anhui Province, 238000, China.
Zhenkuo Li *Department of Psychiatry, The Fifth People's Hospital of Xiangtan City, Xiangtan, Hunan Province, China.
Jiawei Wang *Department of Psychiatry, Bozhou People's Hospital, Bozhou, Anhui Province, China.
Lili ZhaoDepartment of Psychiatry, School of Mental Health and Psychological Sciences, Anhui Medical University, Hefei, Anhui Province, China.
Xi ZhangDepartment of Psychiatry, School of Mental Health and Psychological Sciences, Anhui Medical University, Hefei, Anhui Province, China.
Yinghan TianDepartment of Psychiatry, The Fourth Affiliated Hospital of Anhui Medical University, 64 Chaohu North Road, Hefei, Anhui Province, 238000, China.
Xianhu YaoDepartment of Psychiatry, Ma'anshan Fourth People's Hospital, Ma'anshan, Anhui Province, China.
Wenzheng LiDepartment of Psychiatry, Hefei Fourth People's Hospital, Hefei, Anhui Province, China.
Lei XiaDepartment of Psychiatry, The Fourth Affiliated Hospital of Anhui Medical University, 64 Chaohu North Road, Hefei, Anhui Province, 238000, China. xialei@ahmu.edu.cn.
Huanzhong LiuDepartment of Psychiatry, The Fourth Affiliated Hospital of Anhui Medical University, 64 Chaohu North Road, Hefei, Anhui Province, 238000, China. huanzhongliu@ahmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic schizophrenia is commonly associated with a high incidence of insomnia. Co-morbid insomnia not only exacerbates psychiatric symptoms but also significantly impairs cognitive functioning, and increases the risk of suicide. Therefore, this study sought to explore the relationships between insomnia symptoms and clinical features, lipid metabolism parameters, and inflammatory cytokines in patients with chronic schizophrenia, thereby providing a scientific basis for early identification and intervention of insomnia in this population.

methodsFrom May to December 2018, 317 patients with chronic schizophrenia were included. General demographic data were collected using a self-administered questionnaire. Insomnia, psychotic symptoms, and depression were assessed using a series of validated scales. Additionally, plasma levels of lipid metabolism parameters and inflammatory cytokines, including interleukin (IL)-1β, IL-6, IL-17 A, and tumor necrosis factor-α (TNF-α), were measured. Finally, logistic regression analysis was conducted to identify the independent predictors of insomnia symptoms.

resultsAmong patients with chronic schizophrenia, 42.3% exhibited insomnia symptoms. Univariate analyses revealed that, compared to the non-insomnia group, patients in insomnia group were older and had higher positive symptom scores, higher general psychopathology scores, higher total scores on the Calgary Depression Scale (CDSS), and elevated plasma levels of Log IL-6 (all p < 0.05). Furthermore, regression analyses identified age (OR = 1.027, 95% CI = 1.005-1.048, p = 0.013), CDSS total score (OR = 1.265, 95% CI = 1.163-1.375, p < 0.001), and Log IL-6 level (OR = 2.053, 95% CI = 1.251-3.371, p = 0.004) as independent correlates of insomnia.

conclusionPatients with chronic schizophrenia are at a relatively high risk of developing insomnia. Insomnia symptoms may be associated with age, psychotic symptoms, depressive symptoms, and elevated levels of IL-6. Based on these findings, clinical staff should enhance the monitoring and assessment of sleep quality in patients with chronic schizophrenia and implement targeted early interventions for those at risk of insomnia.

Indexed as

CytokinesLipid MetabolismSchizophreniaSleep Initiation and Maintenance DisordersAdultChronic DiseaseFemaleHumansInterleukin-6MaleMiddle AgedCytokinesInterleukin-6Chronic schizophreniaClinical featuresInflammatory cytokinesInsomniaLipid metabolism

Identifiers

PMID40877832
PMCPMC12392616

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.